227 related articles for article (PubMed ID: 10929797)
21. [Neuroleptic treatment and neurological soft signs in schizophrenic patients].
Mechri A; Slama H; Chebel S; Mandhouj O; Gaha L
Therapie; 2007; 62(5):449-53. PubMed ID: 18206107
[TBL] [Abstract][Full Text] [Related]
22. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Gaffney GR; Tune LE
J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
[TBL] [Abstract][Full Text] [Related]
23. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
[TBL] [Abstract][Full Text] [Related]
24. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
Linden M; Scheel T; Eich FX
J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
[TBL] [Abstract][Full Text] [Related]
25. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
Chamorro García L
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
[TBL] [Abstract][Full Text] [Related]
26. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
Chouinard G; Annable L; Steinberg S
J Clin Psychopharmacol; 1986 Feb; 6(1):21-6. PubMed ID: 3512622
[TBL] [Abstract][Full Text] [Related]
27. [Neuroleptic induced deficit syndrome].
Szafrański T
Psychiatr Pol; 1995; 29(3):359-69. PubMed ID: 7652089
[TBL] [Abstract][Full Text] [Related]
28. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
29. [Psychopathology of schizophrenia and brain imaging].
Gross G; Huber G
Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
[TBL] [Abstract][Full Text] [Related]
30. Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.
Chakos MH; Mayerhoff DI; Loebel AD; Alvir JM; Lieberman JA
Psychopharmacol Bull; 1992; 28(1):81-6. PubMed ID: 1609046
[TBL] [Abstract][Full Text] [Related]
31. [Perospirone therapy in elderly patients with schizophrenia].
Masui T; Honma H; Kondo C; Osawa T; Iwasaki S; Matsubara S
Seishin Shinkeigaku Zasshi; 2003; 105(10):1247-53. PubMed ID: 14679781
[TBL] [Abstract][Full Text] [Related]
32. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
Lisoprawski A
Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
[TBL] [Abstract][Full Text] [Related]
33. Subjective experiences and the psychopathological dimensions in schizophrenia.
Yon V; Loas G; Brien D
Psychiatry Res; 2005 Nov; 137(1-2):93-102. PubMed ID: 16213596
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
Mishara AL; Goldberg TE
Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
[TBL] [Abstract][Full Text] [Related]
35. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
Bralet MC; Yon V; Loas G; Noisette C
Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
[TBL] [Abstract][Full Text] [Related]
36. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.
Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA
Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003
[TBL] [Abstract][Full Text] [Related]
37. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
38. Déjà vu experiences in schizophrenia: relations with psychopathology and antipsychotic medication.
Adachi N; Adachi T; Akanuma N; Matsubara R; Ito M; Takekawa Y; Ikeda H; Arai H
Compr Psychiatry; 2007; 48(6):592-6. PubMed ID: 17954146
[TBL] [Abstract][Full Text] [Related]
39. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
[TBL] [Abstract][Full Text] [Related]
40. Neuroleptic dose reduction in older psychotic patients.
Harris MJ; Heaton RK; Schalz A; Bailey A; Patterson TL
Schizophr Res; 1997 Oct; 27(2-3):241-8. PubMed ID: 9416653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
